Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Is Carboplatin and Oral Etoposide an Effective and Feasible Regimen in Patients with Small Cell Lung Cancer?

By Pfeiffer P.   Sorensen P.   Rose C.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 64-69

Elsevier

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

By Helsing M.   Bergman B.   Thaning L.   Hero U.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1036-1044

Elsevier

Access to resources Recommend Favorite

Evaluation of carboplatin dosing in non-small cell lung carcinoma patients using Calvert formula and Cockroft and Gault equation for glomerular filtration rate estimation

By          

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1072-1076

Spandidos Publications

Access to resources Recommend Favorite